Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation

Wilby, J; Kainth, A; Hawkins, N; Epstein, D; McIntosh, H; McDaid, C; Mason, A; Golder, S; O'Meara, S; Sculpher, M; +2 more... Drummond, M; Forbes, C; (2005) Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health technology assessment, 9. 1-157, iii. ISSN 1366-5278 DOI: https://doi.org/10.3310/hta9150

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.3310/hta9150

Abstract

Share

Download

Filename: Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults.pdf

Licence: Copyright the publishers

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar